Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections ...Middle East

SHANGHAI and HONG KONG, July 25, 2021 /PRNewswire/ -- In June 2021, results from a preclinical study jointly conducted by Antengene, American biopharmaceutical company Karyopharm Therapeutics and University of Georgia College of Veterinary Medicine has been published in a paper titled...

Hence then, the article about antengene and its partners publish preclinical data demonstrating the encouraging activity of selinexor in the prevention and treatment of sars cov 2 infections was published today ( Monday 26/07/2021 - 04:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections )

Also on site :

• The ‘rules-based order’ has failed in its mission – helping the West do whatever it wants
• Armed police close Lewes Road
• Intrigue, Power Plays and Rivalries: Inside the Rise of Mojtaba Khamenei